XML 28 R13.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Equity Method and Other Investments
 3 Months Ended
Mar. 31, 2024
Investments, Debt and Equity Securities [Abstract]  
Equity Method Investments and Joint Ventures Disclosure Equity method and other investments
The Company maintains equity method and other minor investments in the private securities of certain other healthcare and healthcare-related businesses as follows:
March 31, 2024December 31, 2023
Mozarc Medical Holdings LLC$303,243 $324,711 
APAC joint venture68,165 98,865 
Other equity method partnerships105,678 107,282 
Adjusted cost method and other investments15,455 14,990 
$492,541 $545,848 
During the three months ended March 31, 2024 and 2023 the Company recognized equity investment income of $6,682 and $6,820, respectively, from its equity method investments in nonconsolidated dialysis partnerships. The Company also recognized equity investment losses from other equity method investments of $(19,029) and $(2,478) in other (loss) income, net during the three months ended March 31, 2024 and 2023, respectively.
See Note 8 to the Company's consolidated financial statements included in the 2023 10-K for further description of the Company's equity method investments.